Electron beam effect on biomaterials I: focusing on bone graft materials by unknown
Kim et al. Biomaterials Research  (2015) 19:10 
DOI 10.1186/s40824-015-0031-5RESEARCH ARTICLE Open AccessElectron beam effect on biomaterials I: focusing
on bone graft materials
Soung Min Kim1, Huan Fan1, Yun Ju Cho1, Mi Young Eo1, Ji Hyun Park2, Byung Nam Kim3, Byung Cheol Lee2
and Suk Keun Lee4*Abstract
Background: To develop biocompatible bony regeneration materials, allogenic, xenogenic and synthetic bones
have been irradiated by an electron beam to change the basic structures of their inorganic materials. The optimal
electron beam energy and individual dose have not been established for maximizing the bony regeneration capacity
in electron beam irradiated bone.
Results: Commercial products consisting of four allogenic bones, six xenogenic bones, and six synthetic bones were
used in this study. We used 1.0-MeV and 2.0 MeV linear accelerators (power: 100 KW, pressure; 115 kPa, temperature; -30
to 120°C, sensor sensitivity: 0.1-1.2 mV/kPa, generating power sensitivity: 44.75 mV/kPa, supply voltage: 50.25 V), and a
microtrone with different individual irradiation doses such as 60 kGy and 120 kGy. Additional in vitro analyses were
performed by elementary analysis using field emission scanning electron microscopy (FE-SEM), scanning electron
microscopy (SEM), X-ray diffraction (XRD) and confocal laser scanning microscopy (CLSM). In vivo clinical, radiographic, and
micro-computed tomography (Micro-CT) with bone marrow density (BMD) analysis was performed in 8- and 16-week-old
Spraque-Dawley rats with calvarial defect grafts.
Conclusions: Electron beam irradiation of bony substitutes has four main effects: the cross-linking of biphasic calcium
phosphate bony apatite, chain-scissioning, the induction of rheological changes, and microbiological sterilization. These
novel results and conclusions are the effects of electron beam irradiation.
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Electron beam irradiation (EBI), or electron beam pro-
cessing, is a process that uses electrons, usually of high
energy, to treat objects for purposes such as sterilization
and the cross-linking of polymers. Electron beams have
been used in research, technology, and medical therapy
to produce images on television screens, and are also
used for electron microscopes for the ultramicroscopic
analysis of materials [1-3].
For the successful regeneration of grafted bone mate-
rials in the human body, many factors including bone
composition and the bony matrix must be considered
(Figure 1) [1,4]. The four basic desired properties of bone
graft materials are osteogenesis, osteoinduction, osteo-
conduction, and osteointegration. Only autogenous bone* Correspondence: sukkeunlee@hanmail.net
4Department of Oral Pathology, College of Dentistry, Gangneung-Wonju
National University, 123 Chibyon-dong, Gangneung 210-702, South Korea
Full list of author information is available at the end of the article
© 2015 Kim et al.; licensee BioMed Central. Th
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.has these four qualities, so many studies have been per-
formed investigating the development of ideal bone
graft materials from allogenic, xenogenic, and synthetic
graft materials.
During our recent investigations of the effec of EBI
on maxillofacial reconstructive polymer materials, we
have tried to identify gross changes in the substitute
bone materials. To advance the study of applying bio-
material in hard-tissue reconstruction, this article is
intended to suggest new possibilities for electron beam
treatment of bone graft materials.Methods
Preparation of electron beam-irradiated bone
To prepare the electron beam-irradiated bone, we first ob-
tained commercially available samples consisting of four
allogenic bones, six xenogenic bones, and six synthetic
bones. We used 1.0-MeV and 2.0-MeV linear acceleratorsis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Schematic drawing of the basic compositions of human bone.
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120°C, sensor sensitivity: 0.1-1.2 m V/kPa, generating
power sensitivity: 44.75 mV/kPa, supply voltage: 50.25 V),
and a microtrone with different individual irradiation
doses such as 60 kGy and 120 kGy.
The allogenic bone materials were Accell® (ISOTIS
OrthogBiologics Inc., Irvine, USA), Allotis® (BioTis Bone
Bank, Seoul, Korea), Oragraft® (LifeNet, Virginia Beach,
VA, USA), and Orthoblast® (Integra Orthobiologics Inc.,
Irvine, USA). The xenogenic bone materials were BBP®
(OscoTec Inc., Seongnam, Korea), Bio-cera® (OscoTec
Inc., Seongnam, Korea), Bio-oss® (Geistlich Pharma AG,
Wolhusen, Switzerland), Indu-cera® (OscoTec Inc.,
Seongnam, Korea), OCS-B® (Nibec Co., Seoul, Korea),
and OCS-H® (Nibec Co., Seoul, Korea). The synthetic
bone materials were BMP® (Cowellmedi Co., Seoul,
Korea), BoneMedik® (Meta Biomed Co., Cheongju,
Korea), Boneplus® (Megagen Co., Seoul, Korea), MBCP®
(Biomatlante, vigneux de Bretagne, France), Osteon®
(Genoss, Suwon, Korea), and Osteogen® (Impladent Ltd.,
Hollis, USA).Figure 2 Basic study designs showing the electron beam irradiated bone mIn vitro analyses
After the irradiation of all specimens under strict dose calcu-
lations (Figure 2), all specimens were analyzed in vitro by
elementary analysis with an EA 1110® elementary analyzer
(CE instruments Co., Milan, Italy) using cold field emission.
To observe the changed ultra-structures and to detect their
elementary components, a Leo1455VP-SEM® (Carl Zeiss
Inc., Aalen, Germany) scanning electron microscope (SEM),
and S-4200® (Hitachi Co., Tokyo, Japan) field emission scan-
ning electron microscope (FE-SEM) were also used. For the
analysis of the molecular changes after EBI, 8D advance®
(Bruker Co., Berlin, Germany) X-ray diffraction (XRD) ana-
lysis was performed. The three-dimensional changes on the
surfaces of the specimen were evaluated with a LSM 5
Pascal® (Carl Zeiss Inc., Aalen, Germany) confocal laser
scanning microscope (CLSM).
Clinical and bone marrow density evaluation after the
grafting of calvarial defects of Sprague-Dawley rat
We compared possible differences in each bone mater-
ial before and after EBI, and each bone materials wasaterials, according to their origin, energy, and radiation dose.
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Dawley rats. Evaluation at 8 and 16 weeks was performed
(Figure 3).
In total, 48 Sprague-Dawley male rats (each weigh-
ing 200-230 g) were anesthetized with a mixture of
Ketamine® (60 mg/kg, ketamine hydrochloride; Yuhan
Co., Korea) and Rompun® (3 mg/kg, xylazine hydro-
chloride; Bayer Korea, Korea) in a 4:1 ratio. The rats’
bilateral frontal bones were exposed (Figure 4A) and
perforated with a round bur (5.0 mm diameter; Shinhung
Co., Korea) so as not to damage the internal brain tissue
(Figure 4B). The result was a round bone perforation
measuring 5 mm in diameter, and the perforated bone
wound was filled with each bone graft materials (Figure 4C).
After implantation, the wound was covered by a periosteal
membrane suture using 5-0 Vicryl® (Johnson & Johnson
Co., USA), followed by a tight suture of the incised skin with
4-0 Nylon® (Ailee Co., Korea). After surgery, animals were
kept warm in their individual cages until theymade a full re-
covery from the anesthesia and were then returned to the
holding room with free access to water and food. Tarasyn®
(2 mg/kg, ketorolac tromethamine; Yuhan Co., Korea) was
given to each animal subcutaneously for 3 days to reduce
any postoperative pain, and Icepacin® (1.5 mg/kg, icepacin
sulfate; Yuhan Co., Korea) was used for 3 days to prevent
postoperative infection.
The skin wounds healed uneventfully after two weeks.
A group of rats was sacrificed by intramuscular injection
of 50% Urethane® (U2500, 1.5 g/kg; Sigma-Aldrich Co.,
USA) at 8 (Figure 4D) and 16 weeks (Figure 4E) post-
treatment. The frontal bone tissue, including the perforated
area and covering periosteal membrane, was removed
(Figures 4D,E). Each removed specimen was evaluated
with micro-computed tomography (Micro-CT) with bone
marrow density (BMD) calculations.Light microscope observation of the regenerated calvarial
defect
To determine the histological features of the regenerated
bone in the calvarial defect, every specimen was fixed in
10% buffered formalin, decalcified in 4% nitric acid, andFigure 3 Basic units of the electron beam irradiation devices in EB Tech Co
device, and the actual radiation dosages according to the set energy (B), a
of a calvarial defect model grafted with electron beam-irradiated bone maembedded in paraffin. The cross-sectioned area of the
frontal bone containing the perforated area was microsec-
tioned to a thickness of 4 μm and subsequently stained by
hematoxylin and eosin [5]. The cross-sectional microsec-
tions of the regenerated bone were observed under a light
microscope and the histological images were captured by
a DP-70® digital camera (Canon Co., Saitama, Japan).
Statistical analysis
All of the data above were analyzed and compared by
analysis of variance (ANOVA ) using SPSS for Windows®
(Version 12.2, SPSS Inc., USA) and mean values with
95% confidence intervals. Correlations between three dif-
ferent kinds of bone, and between 12 different irradiated
conditions were analyzed by the Pearson's correlation
test (p < 0.05).
Results
Electron beam irradiation to a total of 1,152 specimens
A total of 16 bone materials, including four allogenic, six
xenogenic, and six synthetic bones, were irradiated under
12 different conditions, such as with 1.0 or 2.0 MeV, and
at 60 or 120 kGy. Each bone material was divided into six
specimens for the in vitro study and graft procedures, so
a total of 1,152 specimens were irradiated by the electron
beam (Figure 2).
In vitro analyses after EBI
Specimens were examined to determine that they had
no specific characteristics such as discoloration, broken
powder, or coagulation. The macroscopic structures be-
fore and after EBI did not differ.
In the elementary analysis of the allogenic and syn-
thetic bone materials, no significant difference was found
in the carbon, oxygen, calcium, and phosphorus compo-
nents. In the BBP® and Bio-cera® allogenic bone materials,
some differences according to the irradiaton conditions
were found, but were not significant (Figure 5). The XRD
patterns of the allogenic, xenogenic, and synthetic bone
were identical, with several strong X-ray deflection
peaks that did not differ with different conditions of., Daejeon, South Korea. Specimens holding tables (A), monitoring
nd schematic time-tables of the clinical, radiologic, and histologic study
terials (C).
Figure 4 Implantation of each bone material and the evaluation process showing the exposed bilateral frontal bone of the Sprague-Dawley rat
(A), 5.0-mm-diameter perforations of the frontal bone were created with a round bur, avoiding damage to the internal brain tissues (B), implantation of
each perforated calvarial wound (C), acquired frontal bone tissue including the perforated area and covering periosteal membrane after 8 weeks (D) and
16 weeks (E).
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the three-dimensional construction of less-than-0.1-mm
sized continuous optical sections, each specimen had their
own CLSM images constructed. There were no differences
observed before and after EBI in each specimen.Clinical evaluation and BMD calculations
We compared the specimens for possible clinical differ-
ences before and after EBI, and each bone material was
implanted onto the perforated calvarial defect of the rats
[6,7]. Clinically, there was no swelling, redness, or local
infection around the suture site in all animals. No rats
were lost in the interval period and all had normal-
appearing weight, feeding, and activity during the 8 or
16 weeks.
Incomplete bony healing was found in the horizontal
radiographic view in most animals after 8 weeks under
different electron beam energy and radiation conditions
(Figure 7). There was less radiopacity observed in the
16 weeks specimen as compared to the 8 weeks specimen.
No remarkable changes were found according to differ-
ent electron beam energy or irradiation dose. In the
comparison of the coronal Micro-CT views of the re-
generated frontal bone under each irradiation condition
after 8 and 16 weeks, many of the electron beam-
irradiated xenogenic and synthetic bone materials be-
come hard and dense after 16 weeks of observation
(Figure 8). The BMD after 16 weeks was calculated to
be higher than that after 8 weeks in most of theFigure 5 Elementary analysis of BBP® and Bio-cera® according to the differsynthetic bone materials, but this pattern was not typ-
ical in the allogenic and xenogenic bone materials. This
result suggested that any remaining bone particles did
not undergo osteogenesis. For example, the BMD of
BMP® was statistically higher under 1 MeV-60 kGy and
2 MeV-60 kGy conditions, but xenogenic bone such as
Bio-cera® showed no special characteristics and did not
show statistical significance (Figure 9).
Light microscopic observation of the regenerated
calvarial defect
To determine the histological features of the regenerated
bone in the calvarial defect, every specimen was ob-
served under the light microscope. Histologically, new
bone formation was more active in the synthetic bone
materials than in the allogenic or xenogenic bone mate-
rials. The allogenic bone materials showed slightly more
regenerative activity than the xenogenic bone materials.
The BMP® grafted bone showed the most regenerative
tendencies with bone marrow calcification at 8 weeks.
However, there were neither remarkable differences, nor
statistical significance in the samples between 8 and
16 weeks (Figure 10).
Discussion
The application of nanotechnology in biomaterials en-
gineering is one of the fastest growing areas in tissue en-
gineering [8,9]. Radiation has been shown to be a useful
tool to arrange atoms and ions with ion or electron
beams. All radiation stems from ionizing radiation thatent conditions of EBI.
Figure 6 The X-ray diffraction (XRD) patterns of BMP® with several strong X-ray deflection peaks noted not to change with different EBI conditions.
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highly accelerated electrons [9-11].
For medical radiotherapeutical or engineering pur-
poses, the most common form of radiation involves
photons, with energies up to KeV and MeV and elec-
trons with energies in the range between 4 and 15 MeV.
In an X-ray tube, the cathode produces electrons by
thermionic emission and acts as an electron source,
with these electrons impinging on the positively charged
anode after being accelerated in a strong electric field.
The kinetic energy of the electrons is converted into X-
radiation and then bremsstrahlung upon deceleration.Figure 7 Horizontal radiographic views of the BMP® implanted frontal bone a
2 MeV-60 kGy (D), and 2 MeV-120 kGy (E).The anode is composed of a high atomic-number mater-
ial with a large bremsstrahlung cross-section and a high
probability for producing bremsstrahlung, with about
99% of the kinetic energy of the electrons striking the
anode transformed into thermal energy [8,9].
Charged particles produces electromagnetic radi-
ation when they interact with matter, which is emitted
as a characteristic line spectrum with energies typical
for the emitting element, as well as bremsstrahlung
with a continuous spectrum. Because of their large e/m
(charge divided by mass) ratio, which is much greater
than the e/m ratio for other charged particles likefter 8 weeks, no beam treatment (A), 1 MeV-60 kGy (B), 1 MeV-120 kGy (C),
Figure 8 Comparison of the coronal Micro-CT views of the regenerated frontal bone under the different conditions after 8 and 16 weeks (right)
of the electron beam-irradiated BMP® implantation. No beam treatment (A,F), 1 MeV-60 kGy (B,G), 1 MeV-120 kGy (C,H), 2 MeV-60 kGy (D,I), and
2 MeV-120 kGy (E,J).
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significantly more bremsstrahlung. For commercial use,
the most important characteristics for an accelerator are
its electron energy and average beam power. Industrial
electron accelerators are usually classified according to
their energy range, which is classified as low (80-300 keV),
medium (300 keV - 5MeV), and high (above 5 MeV) [8,9].
EBI or electron beam processing is a process that in-
volves using electrons, usually of high energy, to treat
an object for a variety of purposes under elevated tem-
peratures and a nitrogen atmosphere. EBI is also used
to treat products with a high-energy electron beam
accelerator which utilizes an on-off technology with a
common design similar to that of a cathode ray televi-
sion. Electron energies typically fall within the keV to
MeV ranges, depending on the depth of penetration
required. The basic components of a typical electron
beam processing device are an electron gun, dose
chamber, magnet, emitter, grid, anode, and deflection
coil [1,3]. The electron gun is used to generate and
accelerate the primary beam, while the magnetic op-
tical focusing lens and deflection coil are used for con-
trolling the way in which the electron beam impinges on
the specimens (Figure 11). The cathode emitter is a
source of thermally-emitted electrons that are both ac-
celerated and shaped into a collimated beam by theFigure 9 Comparison of bone marrow density in the Bio-cera® and BMP®
2 MeV-60 Gy irradiated BMP®.electrostatic field geometry established by the grid and
anode. The electron beam then emerges from the gun
assembly through an exit hole in the ground-plane anode
with an energy equal to the value of the negative high volt-
age being applied to the cathode. This use of a direct high
voltage to produce a high-energy electron beam allows the
conversion of input AC power to beam power at a greater
than 95% efficiency, making electron beam material pro-
cessing a highly energy-efficient technique. After exiting
the gun, the beam passes through an electromagnetic
focusing lens and magnetic deflection coil system. This
focusing lens is used for producing either a focused or de-
focused beam spot on the specimens, while the deflection
coil is used to either position the beam spot on a stationary
location or provide some form of oscillatory motion [1,3,8].
EBI technology has been used in the engineering
and manufacturing industry, mainly for product modi-
fications. The first modification is the cross-linking of
polymer-based products to improve their mechanical,
thermal, chemical properties. The second purpose is
for degradation, often used in the recycling of mate-
rials. The third purpose is for the sterilization of med-
ical and pharmaceutical goods.
Cross-linking is the interconnection of adjacent long
molecules with networks of bonds induced by chemical
treatment or EBI. The cross-linking of polymers throughbone materials, showing a slight increase in the 1 MeV-60 Gy and
Figure 10 Photomicrographs of the regenerated frontal bone after 8 (left) and 16 weeks (right) after electron beam-irradiated BMP® implantation,
with the coronal views of each condition are compared.
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material making the polymer stable against heat by the
impedance of molecular movement [5]. The benefits of
cross-linking is due to the locking effect of molecules,
which improves several properties including thermal re-
sistance to high and low temperature, resistance to
aging, mechanical strength (including tensile, modulus,
abrasion resistance and creep resistance), chemical stress
crack resistance, and heat shrink memory properties.
Commonly cross-linked polymers include polyvinyl chlor-
ide (PVC), thermoplastic polyurethanes and elastomersFigure 11 Schematic drawings of the basic electron beam accelerator includin
and magnetic deflection coil. This accelerator includes the beam-defining system(TPUs), polybutylene terephthalate (PBT), polyvinylidene
fluoride (PVDF), polymethylpentene (PMP), polyethylenes,
polyamides and nylons, and ethylene copolymers such
as ethylene-vinyl acetate (EVA) and ethylene tetra-
fluoroethylene (ETFE). An electron beam induces the
chain scissioning and cross-linking of these polymers.
This chain scissioning effect makes the polymer chains
shorter and result in changes in the crystallinity and
microstructure of the materials. In the in vivo results
of this study, some of the synthetic bone powder
showed changes in its crystallinity, suggesting thatg the electron gun, cathodic emitter, grid, anode, magnetic focusing lens
in electron mode.
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vasculature.
Chain-scissioning, also known as polymer degradation,
is the breaking apart of molecular chains to produce mo-
lecular sub-units. The main effect of EBI is to break these
molecular chains and reduce molecular weight. Without
the use of any chemicals, EBI creates a chain-scission
process that has been used to create fine micropowders
from uses ranging from scrap and off-grade materials to
inks and coatings for the automotive industry [12,13]. In
addition, the high-energy electron irradiation lowers the
energy barrier for ferroelectric-paraelectric phase tran-
sition and reduces polarization hysteresis losses in poly-
vinylidene fluoride-trifluoroethylene copolymers, with
some of the energy barrier between calcium phosphate
particles changed to reduce polarization hysteresis after
EBI. Unfortunately, the mechanism underlying this deg-
radation process has not been shown in in vitro ana-
lyses with SEM, XRD, or CLSM [14].
For microbiological sterilization, EBI has the ability to
break the DNA chains of living organisms, such as bac-
teria, resulting in microbial death and rendering the
space they inhabit sterile. EBI has already been used for
the sterilization of medical products, the development of
aseptic packaging materials for foods, as well as for
disinfectants. EBI's sterilization effect can also be applied
in biomaterials, especially bone grafts. For sterilization,
EBI has significant advantages over other methods of
sterilization currently in use. The process is quick, reli-
able, and compatible with most materials, and does not
require any period of quarantine following processing
[15]. For some materials and products that are sensitive
to oxidative effects, the radiation tolerance levels for EBI
may be slightly higher than for gamma exposure. This is
due to the higher dose rates and shorter exposure times
of EBI, which have been shown to reduce the degrada-
tive effects of oxygen [16].
As a means of disinfection for pests and other patho-
gens, EBI could replace antiquated and environmentally
unfriendly methods such as fumigation and chemical
dipping. A significant advantages of EBI is the reduction
of bacterial contamination without compromising dis-
tinctive flavors and sensory properties. Fruits, vegetables,
grains and other food items can also be processed by
EBI to control the population of fruit flies and other in-
sects that use these commodities as a host for propaga-
tion. Given these properties, EBI can be readily used to
advance the use of biomaterials.
CLSM or laser scanning confocal microscopy (LSCM)
are recent technique for obtaining high-resolution op-
tical images with depth selectivity. While a conventional
microscope can see as far into the specimen as the light
can penetrate. While CLSM can only see images one
depth level at a time. The key feature of CLSM is itsability to acquire in-focus images from selected depths, a
process known as optical sectioning [17,18]. Images are
acquired point-by-point and reconstructed in a com-
puter, allowing for the three-dimensional reconstruc-
tions of topologically complex objects, such as synthetic
bone apatite.
Since many materials can form crystals, including
salts, metals, minerals, semiconductors, and various
organic and biological molecules, XRD has been fun-
damental in the development of many scientific fields.
X-ray crystallography is a tool used for identifying the
atomic and molecular structure of a crystal, in which
the crystalline atoms cause a beam of incident X-rays
to diffract into many specific directions [19]. By measur-
ing the angles and intensities of these diffracted beams,
a crystallographer can produce a three-dimensional pic-
ture of the density of electrons within the crystal. From
this electron density, the mean positions of the atoms in
the crystal can be determined, as well as their chemical
bonds, disorder and various other characteristics [20].
In this study, no changes in the peaks or other diffract-
ive patterns in the bone substitutes before and after EBI
were observed with CLSM or XRD. The effect of EBI on
these bone particles could not be observed, so different
approaches to induce bony regeneration are needed.
Various studies have reported the effects of EBI on
various woods and semiconductive metals, but few data
are available regarding the biologic and clinical applica-
tions of EBI on biomaterials.
Rat calvarial defects have been used to evaluate bone
regeneration and survey different materials before clin-
ical application in humans. The rat calvarial defect
protocol involves preparation, surgery, and several ana-
lyses of bone regeneration, which has been described in
our previous publications [1,4,6]. A defect if 8 mm is
generally accepted to be the critical size in the rat calvar-
ial defect model, but smaller defects have been investi-
gated in models with two defects per animal, allowing
fewer animals to be required for a given study. This
study used a model with two 5-mm sized defects per cal-
varium, which has been used to examine the healing of
subcritically sized defects. The potential for interactions
between these two adjacent defects was prevented by
allowing at least a 1.5-mm distance from the middle sa-
gittal suture line. The primary goal of this design was to
compare the regeneration of the bony materials, so the
natural regenerative capacity of these two defects had to
be excluded from the rat model [7].
EBI has four main effects to bony materials. First, it in-
duces the cross-linking of biphasic calcium phosphate
bony apatite, with a thermal effect on its resistance to
temperature changes, a mechanical effect although with
no specific changes to the surface morphology or apatite
structure, and a chemical effect with a slight increase in
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bone, among other effects of irradiation such as changes
in the DNA structure. Second, chain-scissioning causes
the degradation and breaking of bony apatite chains,
such as type I collagen, inducing blood supply formation
and and coagulation near the grafted bony substitutes.
Third, EBI has also been implicated in rheological
changes, especially in BMP-coated apatites. Finally, EBI
results in microbiological sterilization, as previously
described.
The four desired properties of bone graft materials
are osteogenesis, osteoinduction, osteoconduction, and
osteointegration. Osteogenesis is new bone formation
that occurs from osteoprogenitor cells that are present
in the graft, survive the transplant, and proliferate and
differentiate to osteoblasts. Marrow elements provide
the fusion bed with osteoinductive proteins, potential
osteogenic cells, and a local blood supply that make osteo-
genesis possible. Osteoconduction entails the stimulation
and recruitment of nearby undifferentiated mesenchymal
stem cells to the graft site. The stem cells are triggered to
differentiate into chondrocytes and osteoblasts on the
graft site. The method of recruitment and differentiation
occurs through a cascade of events triggered by graft-
derived factors known as BMP -2, -4, and -7, which are
members of the transforming growth factor-ß superfamily.
These BMPs are present in the matrix of the graft and are
accessed after the mineral content of the bone graft has
been removed. In addition to the BMPs, other vital
factors involved in healing include platelet-derived
growth factors, fibroblast growth factors, insulin-like
growth factors, granulocyte colony-stimulating factors,
mitogens, and interleukins. Angiogenic factors, such as
vascular endothelial-derived growth factor, are also
present. Osteoconduction is the ingrowth of vascular
tissue and mesenchymal stem cells into the scaffold
structure presented by the graft material. This is an or-
dered process that results in the formation of new
Haversian systems in a predictable pattern along the
host-graft interface, which subsequently infuses into
the graft material. Osseointegration is described as
the bonding of the host and the graft material. This
phenomenon is vital to graft survival. For the graft to
be functional, an inadequate amount of new bone must
exist in the graft and unite with the host bone [21-23].
There are no organic or protein-related factors in the
xenogenic and synthetic bone materials. Calcified or
mineralized bone matrix has no osteoinductive proper-
ties and the BMPs are encased by the bone minerals, so
the content of the allograft directly affects how add-
itional proteins or factors can be used at the grafting
site. The osteoinductive property is elevated with de-
creasing mineral content in the graft, with growth fac-
tors more available for the stimulation of mesenchymalcells. EBI has been suggested to have demineralization
effects by creating new vacant spaces or micro-sized
voids in the bony apatite. Within this space, a new
vascular supply can be created for both osteoinduction
and osteoconduction. Although any reduction in min-
eral content decrease mechanical strength of the graft,
the scissoning effect of EBI can mitigate this decrease
in mechanical strength.
As we have previously reported [1,2], type I collagen
contributes to mineral deposition, vascular ingrowth,
and growth factor binding, which provides a favorable
environment for grafed bone regeneration. Type I collagen
has the potential for immunogenicity and has diminished
structural integrity. EBI can induce bone apatite to be
incorporated and combined with type I collagen and
BMPs.
Xenografts are derived from genetically different spe-
cies. One of the most used xenograft is bovine bone,
with Bio-oss® being the best-known example. These de-
proteinized bovine bone minerals have been treated so
that all of their organic materials have been removed.
The application of these bones results in a crystal struc-
ture that practically matches human cancellous bone. In
this study, the bone samples after 8 and 16 weeks of
Bio-cera® showed some differences after EBI, with par-
ticle sizes of 0.25 to 1 mm, which are the dimensions
that are thought to promote osteogenesis. 75% of its
volume of Bio-oss® is known to be contained in a porous
scaffold, so this structure greatly increases surface area
and results in a material that is useful for osteoconduc-
tion. However, due to its large porous nature, the initial
stability of Bio-oss® remains an issue. Treatment of Bio-oss®
with EBI can increase angiogenesis and enhance further
new bone growth.Conclusions
The use of EBI on synthetic bone has thermal, mechan-
ical, and chemical effects on the cross-linking of bi-
phasic calcium phosphate apatites. Another effect of
chain-scissioning is the degradation or breaking of bony
apatite chains, which can induce blood supply formation
and coagulation near the grafted bony substitutes.Availability of supporting data
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